Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vir Biotechnology, Inc. (VIR)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 127,390,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 10,000
Total Buy Value $0 $0 $0 $246,341
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 4
Total Shares Sold 81,714 167,399 501,617 6,000,552
Total Sell Value $777,020 $1,671,921 $10,423,624 $153,832,815
Total People Sold 3 5 7 11
Total Sell Transactions 3 10 20 121
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 575
  Page 12 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pang Phillip Chief Medical Officer   •       –      –    2022-01-05 4 OE $1.53 $7,650 D/D 5,000 97,777     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-28 4 AS $39.95 $54,931 D/D (1,375) 107,700     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-28 4 OE $1.53 $2,104 D/D 1,375 109,075     -
   Nelsen Robert Director   –       •       •   2021-12-20 4/A A $0.00 $0 D/D 102,041 247,546     -
   Bybee Clinton 10% Owner   –       –       •   2021-12-20 4 A $0.00 $0 D/D 61,207 38,589     -
   Bybee Clinton 10% Owner   –       –       •   2021-12-20 4 D $0.00 $0 I/I (1,750,000) 10,677,283     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2021-12-20 4 S $52.73 $21,093,160 I/I (400,022) 22,216,644     -
   Nelsen Robert Director   –       •       •   2021-12-20 4 A $0.00 $0 D/D 102,041 244,172     -
   Nelsen Robert Director   –       •       •   2021-12-20 4 D $0.00 $0 I/I (1,750,000) 10,677,283     -
   Sato Vicki L Director   –       •      –    2021-12-20 4 AS $51.87 $827,485 D/D (15,174) 1,551,092     -
   Pang Phillip Chief Medical Officer   •       –      –    2021-12-15 4 AS $49.41 $253,608 D/D (5,000) 92,777     -
   Pang Phillip Chief Medical Officer   •       –      –    2021-12-15 4 OE $1.53 $7,650 D/D 5,000 97,777     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-15 4 AS $50.00 $137,500 D/D (2,750) 107,700     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-15 4 OE $1.53 $4,208 D/D 2,750 110,450     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-14 4 AS $45.88 $63,085 D/D (1,375) 107,700     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-12-14 4 OE $1.53 $2,104 D/D 1,375 109,075     -
   Pang Phillip Chief Medical Officer   •       –      –    2021-12-01 4 AS $41.82 $325,841 D/D (7,500) 92,777     -
   Nelsen Robert Director   –       •       •   2021-11-29 4 A $0.00 $0 D/D 29,153 142,131     -
   Nelsen Robert Director   –       •       •   2021-11-29 4 D $0.00 $0 I/I (500,000) 11,665,050     -
   Sato Vicki L Director   –       •      –    2021-11-26 4 AS $36.80 $558,403 D/D (15,174) 1,566,266     -
   Bybee Clinton 10% Owner   –       –       •   2021-11-22 4 A $0.00 $0 D/D 17,485 18,657     -
   Bybee Clinton 10% Owner   –       –       •   2021-11-22 4 D $0.00 $0 I/I (500,000) 11,947,269     -
   Pang Phillip Chief Medical Officer   •       –      –    2021-11-17 4 AS $35.75 $179,255 D/D (5,000) 100,277     -
   Pang Phillip Chief Medical Officer   •       –      –    2021-11-17 4 OE $5.18 $25,875 D/D 5,000 105,277     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2021-11-16 4 AS $32.67 $44,921 D/D (1,375) 107,700     -
  575 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us